Alignment Healthcare shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $9 to $10.
Portfolio Pulse from Benzinga Newsdesk
Raymond James has upgraded Alignment Healthcare's stock from Outperform to Strong Buy and raised its price target from $9 to $10. This has resulted in Alignment Healthcare shares trading higher.
October 16, 2023 | 1:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alignment Healthcare's stock has been upgraded by Raymond James from Outperform to Strong Buy, with a price target increase from $9 to $10. This has led to a rise in the company's share price.
The upgrade from Raymond James, a well-respected financial institution, is a strong positive signal for Alignment Healthcare. The increase in the price target from $9 to $10 also indicates a positive outlook for the company's stock. This news has already resulted in the company's shares trading higher, and it is likely to continue to have a positive impact in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100